Use of leftover samples for COVID-19 diagnostic evaluations V.1.0 [COVID-19]

• Research type

  Research Study

• Full title

  Use of leftover samples for COVID-19 diagnostic evaluations

• IRAS ID

  287692

• Contact name

  Tom Fletcher

• Contact email

  Tom.Fletcher@lstmed.ac.uk

• Sponsor organisation

  Liverpool School of Tropical Medicine

• Clinicaltrials.gov Identifier

  20-060, Study number

• Duration of Study in the UK

  0 years, 5 months, 5 days

• Research summary

  This project will evaluate diagnostic tests for the Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) causing the Coronavirus Disease 19 (COVID-19) outbreak. We are proposing to use leftover serum samples from the Liverpool Clinical Laboratories (LCL) and Alder Hey Children’s Hospital. Our research team is closely working with the Foundation of New Diagnostics (FIND) to complete comparative evaluations of rapid diagnostic tests (RDT) and enzyme-linked immunosorbent assays (ELISA) that detect human antibodies specific to SARS-CoV-2.

• REC name

  East Midlands - Nottingham 1 Research Ethics Committee

• REC reference

  20/EM/0202

• Date of REC Opinion

  10 Aug 2020

• REC opinion

  Favourable Opinion